style="font-size:15px;"> 55 55. Ward EG, Disch WB, Schensul JJ, Levy JA. Understanding low‐income, minority older adult self‐perceptions of HIV risk. J Assoc Nurses AIDS Care. 2011; 22(1):26–37. doi:10.1016/j.jana.2010.05.002.56 56. Reece M, Herbenick D, Schick V, Sanders SA, Dodge B, Fortenberry JD. Condom use rates in a national probability sample of males and females ages 14 to 94 in the United States. J Sex Med. 2010; 7 Suppl 5:266–76. doi:10.1111/j.1743‐6109.2010.02017.x.
57 57. Adolescents. PoAGfAa. Guidelines for the use of antiretroviral agents and adolescents with HIV. Department of Health and Human Services. 2016. http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf.
58 58. Fleishman JM, Crane B, Koch PB. Correlates and predictors of sexual satisfaction for older adults in same‐sex relationships. J Homosex. 2019; 67(14):1–25. doi:10.1080/00918369.2019.1618647.
59 59. Klitzman RL, Greenberg JD. Patterns of communication between gay and lesbian patients and their health care providers. J Homosex. 2002; 42(4):65–75. doi:10.1300/J082v42n04_04.
60 60. Abner EL, Teaster PB, Mendiondo MS, et al. Victim, allegation, and investigation characteristics associated with substantiated reports of sexual abuse of adults in residential care settings. Journal of Interpersonal Violence. 2019; 34(19):3995–4019. doi:10.1177/0886260516672051.
61 61. Speck PM, Hartig MT, Likes W, et al. Case series of sexual assault in older persons. Clin Geriatr Med. 2014; 30(4):779–806. doi:10.1016/j.cger.2014.08.007.
CHAPTER 6 Ageing of the brain
Marco Canevelli1,2 and Luca Marsili3
1 Department of Human Neuroscience, Sapienza University, Rome, Italy
2 National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy
3 Gardner Family Center for Parkinson’s Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USA
Introduction
The ageing process is associated with structural and functional changes in the nervous system. Understanding the mechanisms and consequences of brain ageing has important implications for a number of reasons. First, the disorders of the ageing brain are one of the largest global healthcare issues. Age‐associated neurological diseases (e.g. stroke, Alzheimer’s disease [AD] and other dementias, Parkinson’s disease [PD]) represent a major cause of mortality and disability worldwide.1 Their public health impact will further increase in the future as a consequence of ongoing sociodemographic transitions. Moreover, most neurodegenerative conditions share some pathophysiological processes, neuropathological modifications, and phenotypic manifestations with the physiological ageing process.2 Therefore, understanding the neurobiological bases of brain ageing can drive fundamental advances in the development of effective therapies aimed at preventing or postponing neurodegenerative pathologies.3 Finally, brain functions and dysfunctions (even when they do not configure overt diseases) are crucial determinants for the main health‐related outcomes, such as mortality and functional dependence. They are also strongly associated with the frailty status of the individual: that is, with their risk of developing unfavourable health trajectories.4 Accordingly, identifying and promoting interventions and lifestyle modifications that might allow the maintenance or improvement of such competencies is essential for healthy ageing.
This chapter focuses on the main morphological changes and biological modifications occurring in the ageing brain. In addition, the central age‐related alterations at the neurological examination and in terms of cognitive functioning are addressed.
Structural age‐related brain changes
The human brain undergoes profound structural changes with ageing, characterized by marked variability in terms of (i) extension, (ii) trajectories, and (iii) impact on brain functions. The study of these modifications, previously based on neuropathological examinations, has greatly improved with the advent of modern neuroimaging techniques. The most common age‐related findings from brain magnetic resonance imaging (MRI) are summarized in Table 6.1.
Atrophy
The brain shrinks during normal ageing, with reductions in both grey and white matter.
A progressive decrease of grey matter volume is observed in older adults, with studies describing both linear effects across age and nonlinear trends.5 The cortical mantle becomes thinner, which is typically associated with the enlargement of ventricles and greater cerebrospinal fluid volumes. Some brain regions seem more susceptible to grey matter atrophy. Specifically, common patterns of atrophy involving the prefrontal cortex and, to a lesser extent, the medial temporal lobe and the parietal cortex have been described with ageing.5‐7 Conversely, the primary motor and sensory cortices are relatively spared and show less pronounced age effects.6,7 These modifications are consistent with a ‘last in, first out’ hypothesis of age‐related atrophy.8 That is, brain regions that are last to develop are the first to atrophy. This model has been supported by recent evidence that age‐related brain degeneration mirrors developmental maturation, with networks of higher‐order regions (i.e. lateral prefrontal cortex, frontal eye field, intraparietal sulcus, superior temporal sulcus, posterior cingulate cortex, and medial temporal lobe) that develop late during adolescence degenerating first in old age.9 Subcortical structures such as the cerebellum and caudate nucleus also show reduced volumes in older individuals5.
Table 6.1 Common structural age‐related changes detectable on anatomic brain MRI.
Source: Modified from Grajauskas et al.13
| MRI change | Description | Best MRI sequences to detect the change |
| Atrophy | Reduction of parenchymal tissue volume; enlargement of ventricles, sulci, and other CSF spaces. It can be diffuse to the entire brain or focally restricted to specific areas (e.g. frontal, medial temporal). | T1WI, T2WI, T2‐FLAIR (optimal) T2*GRE (possible) |
| Lacunes | Fluid‐filled cavities in subcortical areas, 3–15 mm in diameter. More prevalent in the basal ganglia, thalamus, pons, internal capsule, and cerebral white matter. | T2WI (optimal) T1WI, T2‐FLAIR (possible) |
| White matter lesions | Patches of abnormal signal intensity seen in the brain’s white matter. Referred to as hyperintensities due to their hypersignal in T2WI. They can consist of periventricular lesions, appearing as caps or patches surrounding ventricles, and/or deep white matter punctate or confluent lesions involving the white matter of cerebral lobes (mostly the frontal lobe). | T2‐FLAIR (optimal) T1WI, T2WI (possible) |
| Microinfarcts |
Tiny areas of necrotic tissue. They are more likely to occur in watershed areas and the cerebral cortex.
|
